(Q36927885)

17 August 2017

Predicting bacterial cause in infectious conjunctivitis: cohort study on informativeness of combinations of signs and symptoms (English)

1 reference

17 August 2017

2

Gerben ter Riet

0 references

author name string

Remco P Rietveld

1

1 reference

17 August 2017

Patrick J E Bindels

3

1 reference

17 August 2017

Jacobus H Sloos

4

1 reference

17 August 2017

Henk C P M van Weert

5

1 reference

17 August 2017

language of work or name

English

0 references

publication date

16 June 2004

1 reference

17 August 2017

5

1 reference

inferred from page(s)

published in

The BMJ

1 reference

17 August 2017

329

1 reference

17 August 2017

7459

1 reference

17 August 2017

206-210

1 reference

Diagnostic impact of signs and symptoms in acute infectious conjunctivitis: systematic literature search

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=487734

Topical antibiotics for acute bacterial conjunctivitis: a systematic review.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=487734

Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=487734

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=487734

Bacterial resistance and therapeutic outcome following three months of topical acne therapy with 2% erythromycin gel versus its vehicle.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=487734

Fusidic acid resistance in Staphylococcus aureus isolates

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=487734

The safety and efficacy of topical norfloxacin compared with placebo in the treatment of acute, bacterial conjunctivitis. The Norfloxacin-Placebo Ocular Study Group

4 September 2018

1 reference

12 December 2020

How do GPs diagnose and manage acute infective conjunctivitis? A GP survey

1 reference

12 December 2020

Topical lomefloxacin 0.3% twice daily versus tobramycin 0.3% in acute bacterial conjunctivitis: A multicenter double-blind phase III study

1 reference

12 December 2020

Topical Lomefloxacin versus Topical Chloramphenicol in the Treatment of Acute Bacterial Conjunctivitis

1 reference

12 December 2020

Acute conjunctivitis. A comparison of fusidic acid viscous eye drops and chloramphenicol

1 reference

12 December 2020

10.1136/BMJ.38128.631319.AE

Identifiers

DOI

1 reference

17 August 2017

1 reference

17 August 2017

PubMed publication ID

15201195

1 reference